Hospital Acquired Infections (HAI) affect nearly 6% of patients in Intensive Care Units or those undergoing surgery, leading to additional costs of USD 28,000/person, and extra 10-14 days of hospitalization.
We develop the next generation of in-situ disinfection technology to prevent pathogenic colonization in and around different catheters. This way, we eliminate the risk of infections and save thousands of lives every year.
Copyright © 2023 Aseptuva AG – Alle Rechte vorbehalten.
Unterstützt von GoDaddy